Clinical Trial

Oral Microbiota Dysbiosis in IBD

Study acronym: MIBD
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to provide new insights into oral microbiota dysbiosis and IBD. Given the strong association between oral health, microbiome composition, and IBD, all participants will undergo an oral evaluation program conducted by dentists from the Faculty of Dentistry at Universidade Católica Portuguesa (UCP). This program will facilitate the characterization of oral health and its correlation with IBD status.
Trial Details
NCT Number NCT06980818
Lead Sponsor ULS Viseu Dão Lafões
Conditions Inflammatory Bowel Disease (IBD), Dysbiosis
Enrollment 130 participants
Start Date 2022-03-11
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-20